Where do ArriVent BioPharma, Inc.'s ratios come from?

Every ratio is computed from ArriVent BioPharma, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Returns
Return on equity	-55.2%-6.2pp	-58.9%—	-52%—	-50.1%—	-49%—
Return on assets	-51.4%-4.5pp	-54.7%-17.9pp	-48.9%—	-47.4%—	-46.9%—
Return on invested capital	-75.6%+107pp	-79.7%—	——	——	-183%—
Liquidity
Current ratio	14×-0.4×	12.8×-0.3×	14.9×-4.4×	12.7×-12.8×	14.3×-18.5×
Quick ratio	14×-0.4×	12.8×-0.3×	14.9×-4.4×	12.7×-12.8×	14.3×-18.5×
Cash ratio	2.5×-1.4×	1.8×-2.5×	5.2×-13.4×	5.7×-18.9×	3.8×-28.0×
Leverage
Debt-to-equity	0×0.0×	0×0.0×	0×0.0×	0×0.0×	0×0.0×
Debt-to-assets	0×0.0×	0×0.0×	0×0.0×	0×0.0×	0×0.0×
Per Share
Book value per share	$7.19+20.3%	$7.99-2.4%	$7.28-11.9%	$7.14-19.4%	$5.97-52.9%
Valuation
Market capitalization	$1.02B+62.1%	$830.58M-7.5%	$748.5M-4.9%	$790.65M+27.3%	$628.96M+5.1%
Enterprise value	$958.05M+65.4%	$785.05M-4.7%	$635.88M+26.0%	$677.99M+110%	$579.23M+106%
Price / book	3.1×0.0×	2.7×-0.8×	2.5×-0.4×	3.2×+1.1×	3.1×+1.2×
Earnings yield	-14.2%+6.0pp	-20%-11.1pp	-20.2%-9.9pp	-17.3%-5.3pp	-20.3%-7.8pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do ArriVent BioPharma, Inc.'s ratios come from?: Every ratio is computed from ArriVent BioPharma, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.